miR-126: a potential new key player in hypoxia and reperfusion?

Affiliations

¹ Transplant and Stem Cell Immunobiology Laboratory, Department of Surgery, University of California, San Francisco, CA, USA;; Transplant and Stem Cell Immunobiology Laboratory, University Heart Centre Hamburg, University of Hamburg, Cardiovascular Research, Hamburg, Germany;; Cardiovascular Research Center (CVRC), University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; German Centre for Cardiovascular Research (DZHK) e.V., University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; Department of Cardiac Surgery, University Hospital Munich, Ludwig-Maximilian-University, Munich, Germany.
² Transplant and Stem Cell Immunobiology Laboratory, Department of Surgery, University of California, San Francisco, CA, USA;; Transplant and Stem Cell Immunobiology Laboratory, University Heart Centre Hamburg, University of Hamburg, Cardiovascular Research, Hamburg, Germany;; Cardiovascular Research Center (CVRC), University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; German Centre for Cardiovascular Research (DZHK) e.V., University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Editorial

Sabina P W Guenther et al. Ann Transl Med. 2016 Oct.

. 2016 Oct;4(19):377.

doi: 10.21037/atm.2016.08.22.

¹ Transplant and Stem Cell Immunobiology Laboratory, Department of Surgery, University of California, San Francisco, CA, USA;; Transplant and Stem Cell Immunobiology Laboratory, University Heart Centre Hamburg, University of Hamburg, Cardiovascular Research, Hamburg, Germany;; Cardiovascular Research Center (CVRC), University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; German Centre for Cardiovascular Research (DZHK) e.V., University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; Department of Cardiac Surgery, University Hospital Munich, Ludwig-Maximilian-University, Munich, Germany.
² Transplant and Stem Cell Immunobiology Laboratory, Department of Surgery, University of California, San Francisco, CA, USA;; Transplant and Stem Cell Immunobiology Laboratory, University Heart Centre Hamburg, University of Hamburg, Cardiovascular Research, Hamburg, Germany;; Cardiovascular Research Center (CVRC), University Medical Center Hamburg-Eppendorf, Hamburg, Germany;; German Centre for Cardiovascular Research (DZHK) e.V., University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Effect and mechanism of miR-126 in myocardial ischemia reperfusion.
Li B, Tao Y, Huang Q. Li B, et al. Genet Mol Res. 2015 Dec 29;14(4):18990-8. doi: 10.4238/2015.December.29.6. Genet Mol Res. 2015. PMID: 26782549

1. Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 2012;13:239-50. 10.1038/nrm3313 - DOI - PMC - PubMed
1. Hsu A, Chen SJ, Chang YS, et al. Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. Biomed Res Int 2014;2014:418628. - PMC - PubMed
1. Li Z, Li N, Wu M, et al. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Mol Cell Biochem 2013;381:233-42. 10.1007/s11010-013-1707-6 - DOI - PubMed
1. Banerjee N, Kim H, Talcott S, et al. Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis 2013;34:2814-22. 10.1093/carcin/bgt295 - DOI - PubMed
1. Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008;373:607-12. 10.1016/j.bbrc.2008.06.090 - DOI - PubMed